Global COVID-19 Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

  • receipt Report ID : 22700
  • calendar_today Published On: Jul, 2020
  • file_copy Pages: 156
  • list Technology
Buy @ $3500

Market Overview

The COVID-19 Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global COVID-19 Drugs sales will be xx in 2020 from COVID-19 Drugs million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global COVID-19 Drugs market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the COVID-19 Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on COVID-19 Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation

COVID-19 Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, COVID-19 Drugs market has been segmented into:

Tablet

Injection

By Application, COVID-19 Drugs has been segmented into:

Mild Symptom Patient

Critically Ill Patient

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global COVID-19 Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level COVID-19 Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global COVID-19 Drugs market.

The report offers in-depth assessment of the growth and other aspects of the COVID-19 Drugs market in important countries (regions), including:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and COVID-19 Drugs Market Share Analysis

COVID-19 Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, COVID-19 Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the COVID-19 Drugs sales, revenue and market share for each player covered in this report.

The major players covered in COVID-19 Drugs are:

Sanofi

Advanz Pharma

Teva

Novartis

Apotex

Shanghai Zhongxisanwei

Kyung Poong

Mylan

Zydus Cadila

Sun Pharma

Rising Pharmaceutical

Guangzhou Baiyunshan Guanghua Pharmaceutical

Ipca Laboratories

KPC Group

Shanghai Pharma

Bayer

Hanlim Pharmaceutical

CSPC Group

Sichuan Sunny Hope

Bristol Laboratories

Jinghua Pharmaceutical Group

Zhongsheng Pharma

North China Pharmaceutical Group

Among other players domestic and global, COVID-19 Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 COVID-19 Drugs Market Overview

1.1 Product Overview and Scope of COVID-19 Drugs

1.2 Classification of COVID-19 Drugs by Type

1.2.1 Global COVID-19 Drugs Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Global COVID-19 Drugs Revenue Market Share by Type in 2019

1.2.3 Tablet

1.2.4 Injection

1.3 Global COVID-19 Drugs Market by Application

1.3.1 Overview: Global COVID-19 Drugs Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Mild Symptom Patient

1.3.3 Critically Ill Patient

1.4 Global COVID-19 Drugs Market by Regions

1.4.1 Global COVID-19 Drugs Market Size by Regions: 2015 VS 2019 VS 2025

1.4.2 Global Market Size of COVID-19 Drugs (2015-2025)

1.4.3 North America (USA, Canada and Mexico) COVID-19 Drugs Status and Prospect (2015-2025)

1.4.4 Europe (Germany, France, UK, Russia and Italy) COVID-19 Drugs Status and Prospect (2015-2025)

1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COVID-19 Drugs Status and Prospect (2015-2025)

1.4.6 South America (Brazil, Argentina, Colombia) COVID-19 Drugs Status and Prospect (2015-2025)

1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COVID-19 Drugs Status and Prospect (2015-2025)

1.5 COVID-19 Outbreak: COVID-19 Drugs Industry Impact

1.5.1 COVID-19 Potential Implications for the COVID-19 Drugs

1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on COVID-19 Drugs

1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April

1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4

1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2

1.5.2 Opportunity Analysis in Covid-19 Crisis

1.5.3 Market Risk and Restraints

1.5.4 Market Driving Force

2 Company Profiles

2.1 Sanofi

2.1.1 Sanofi Details

2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Sanofi SWOT Analysis

2.1.4 Sanofi Product and Services

2.1.5 Sanofi COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.2 Advanz Pharma

2.2.1 Advanz Pharma Details

2.2.2 Advanz Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Advanz Pharma SWOT Analysis

2.2.4 Advanz Pharma Product and Services

2.2.5 Advanz Pharma COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.3 Teva

2.3.1 Teva Details

2.3.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Teva SWOT Analysis

2.3.4 Teva Product and Services

2.3.5 Teva COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.4 Novartis

2.4.1 Novartis Details

2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Novartis SWOT Analysis

2.4.4 Novartis Product and Services

2.4.5 Novartis COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.5 Apotex

2.5.1 Apotex Details

2.5.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Apotex SWOT Analysis

2.5.4 Apotex Product and Services

2.5.5 Apotex COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.6 Shanghai Zhongxisanwei

2.6.1 Shanghai Zhongxisanwei Details

2.6.2 Shanghai Zhongxisanwei Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Shanghai Zhongxisanwei SWOT Analysis

2.6.4 Shanghai Zhongxisanwei Product and Services

2.6.5 Shanghai Zhongxisanwei COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.7 Kyung Poong

2.7.1 Kyung Poong Details

2.7.2 Kyung Poong Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Kyung Poong SWOT Analysis

2.7.4 Kyung Poong Product and Services

2.7.5 Kyung Poong COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.8 Mylan

2.8.1 Mylan Details

2.8.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Mylan SWOT Analysis

2.8.4 Mylan Product and Services

2.8.5 Mylan COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.9 Zydus Cadila

2.9.1 Zydus Cadila Details

2.9.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Zydus Cadila SWOT Analysis

2.9.4 Zydus Cadila Product and Services

2.9.5 Zydus Cadila COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.10 Sun Pharma

2.10.1 Sun Pharma Details

2.10.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Sun Pharma SWOT Analysis

2.10.4 Sun Pharma Product and Services

2.10.5 Sun Pharma COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.11 Rising Pharmaceutical

2.11.1 Rising Pharmaceutical Details

2.11.2 Rising Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Rising Pharmaceutical SWOT Analysis

2.11.4 Rising Pharmaceutical Product and Services

2.11.5 Rising Pharmaceutical COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.12 Guangzhou Baiyunshan Guanghua Pharmaceutical

2.12.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Details

2.12.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 Guangzhou Baiyunshan Guanghua Pharmaceutical SWOT Analysis

2.12.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Product and Services

2.12.5 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.13 Ipca Laboratories

2.13.1 Ipca Laboratories Details

2.13.2 Ipca Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Ipca Laboratories SWOT Analysis

2.13.4 Ipca Laboratories Product and Services

2.13.5 Ipca Laboratories COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.14 KPC Group

2.14.1 KPC Group Details

2.14.2 KPC Group Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 KPC Group SWOT Analysis

2.14.4 KPC Group Product and Services

2.14.5 KPC Group COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.15 Shanghai Pharma

2.15.1 Shanghai Pharma Details

2.15.2 Shanghai Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Shanghai Pharma SWOT Analysis

2.15.4 Shanghai Pharma Product and Services

2.15.5 Shanghai Pharma COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.16 Bayer

2.16.1 Bayer Details

2.16.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 Bayer SWOT Analysis

2.16.4 Bayer Product and Services

2.16.5 Bayer COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.17 Hanlim Pharmaceutical

2.17.1 Hanlim Pharmaceutical Details

2.17.2 Hanlim Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 Hanlim Pharmaceutical SWOT Analysis

2.17.4 Hanlim Pharmaceutical Product and Services

2.17.5 Hanlim Pharmaceutical COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.18 CSPC Group

2.18.1 CSPC Group Details

2.18.2 CSPC Group Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 CSPC Group SWOT Analysis

2.18.4 CSPC Group Product and Services

2.18.3 CSPC Group COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.19 Sichuan Sunny Hope

2.19.1 Sichuan Sunny Hope Details

2.19.2 Sichuan Sunny Hope Major Business and Total Revenue (Financial Highlights) Analysis

2.19.3 Sichuan Sunny Hope SWOT Analysis

2.19.4 Sichuan Sunny Hope Product and Services

2.19.5 Sichuan Sunny Hope COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.20 Bristol Laboratories

2.20.1 Bristol Laboratories Details

2.20.2 Bristol Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.20.3 Bristol Laboratories SWOT Analysis

2.20.4 Bristol Laboratories Product and Services

2.20.5 Bristol Laboratories COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.21 Jinghua Pharmaceutical Group

2.21.1 Jinghua Pharmaceutical Group Details

2.21.2 Jinghua Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis

2.21.3 Jinghua Pharmaceutical Group SWOT Analysis

2.21.4 Jinghua Pharmaceutical Group Product and Services

2.21.5 Jinghua Pharmaceutical Group COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.22 Zhongsheng Pharma

2.22.1 Zhongsheng Pharma Details

2.22.2 Zhongsheng Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.22.3 Zhongsheng Pharma SWOT Analysis

2.22.4 Zhongsheng Pharma Product and Services

2.22.5 Zhongsheng Pharma COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

2.23 North China Pharmaceutical Group

2.23.1 North China Pharmaceutical Group Details

2.23.2 North China Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis

2.23.3 North China Pharmaceutical Group SWOT Analysis

2.23.4 North China Pharmaceutical Group Product and Services

2.23.5 North China Pharmaceutical Group COVID-19 Drugs Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global COVID-19 Drugs Revenue and Share by Players (2015-2020)

3.2 Market Concentration Rate

3.2.1 Top 5 COVID-19 Drugs Players Market Share

3.2.2 Top 10 COVID-19 Drugs Players Market Share

3.3 Market Competition Trend

4 Market Size by Regions

4.1 Global COVID-19 Drugs Revenue and Market Share by Regions

4.2 North America COVID-19 Drugs Revenue and Growth Rate (2015-2020)

4.3 Europe COVID-19 Drugs Revenue and Growth Rate (2015-2020)

4.4 Asia-Pacific COVID-19 Drugs Revenue and Growth Rate (2015-2020)

4.5 South America COVID-19 Drugs Revenue and Growth Rate (2015-2020)

4.6 Middle East & Africa COVID-19 Drugs Revenue and Growth Rate (2015-2020)

5 North America COVID-19 Drugs Revenue by Countries

5.1 North America COVID-19 Drugs Revenue by Countries (2015-2020)

5.2 USA COVID-19 Drugs Revenue and Growth Rate (2015-2020)

5.3 Canada COVID-19 Drugs Revenue and Growth Rate (2015-2020)

5.4 Mexico COVID-19 Drugs Revenue and Growth Rate (2015-2020)

6 Europe COVID-19 Drugs Revenue by Countries

6.1 Europe COVID-19 Drugs Revenue by Countries (2015-2020)

6.2 Germany COVID-19 Drugs Revenue and Growth Rate (2015-2020)

6.3 UK COVID-19 Drugs Revenue and Growth Rate (2015-2020)

6.4 France COVID-19 Drugs Revenue and Growth Rate (2015-2020)

6.5 Russia COVID-19 Drugs Revenue and Growth Rate (2015-2020)

6.6 Italy COVID-19 Drugs Revenue and Growth Rate (2015-2020)

7 Asia-Pacific COVID-19 Drugs Revenue by Countries

7.1 Asia-Pacific COVID-19 Drugs Revenue by Countries (2015-2020)

7.2 China COVID-19 Drugs Revenue and Growth Rate (2015-2020)

7.3 Japan COVID-19 Drugs Revenue and Growth Rate (2015-2020)

7.4 Korea COVID-19 Drugs Revenue and Growth Rate (2015-2020)

7.5 India COVID-19 Drugs Revenue and Growth Rate (2015-2020)

7.6 Southeast Asia COVID-19 Drugs Revenue and Growth Rate (2015-2020)

8 South America COVID-19 Drugs Revenue by Countries

8.1 South America COVID-19 Drugs Revenue by Countries (2015-2020)

8.2 Brazil COVID-19 Drugs Revenue and Growth Rate (2015-2020)

8.3 Argentina COVID-19 Drugs Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue COVID-19 Drugs by Countries

9.1 Middle East & Africa COVID-19 Drugs Revenue by Countries (2015-2020)

9.2 Saudi Arabia COVID-19 Drugs Revenue and Growth Rate (2015-2020)

9.3 UAE COVID-19 Drugs Revenue and Growth Rate (2015-2020)

9.4 Egypt COVID-19 Drugs Revenue and Growth Rate (2015-2020)

9.5 South Africa COVID-19 Drugs Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

10.1 Global COVID-19 Drugs Revenue and Market Share by Type (2015-2020)

10.2 Global COVID-19 Drugs Market Forecast by Type (2019-2024)

10.3 Tablet Revenue Growth Rate (2015-2025)

10.4 Injection Revenue Growth Rate (2015-2025)

11 Global COVID-19 Drugs Market Segment by Application

11.1 Global COVID-19 Drugs Revenue Market Share by Application (2015-2020)

11.2 COVID-19 Drugs Market Forecast by Application (2019-2024)

11.3 Mild Symptom Patient Revenue Growth (2015-2020)

11.4 Critically Ill Patient Revenue Growth (2015-2020)

12 Global COVID-19 Drugs Market Size Forecast (2021-2025)

12.1 Global COVID-19 Drugs Market Size Forecast (2021-2025)

12.2 Global COVID-19 Drugs Market Forecast by Regions (2021-2025)

12.3 North America COVID-19 Drugs Revenue Market Forecast (2021-2025)

12.4 Europe COVID-19 Drugs Revenue Market Forecast (2021-2025)

12.5 Asia-Pacific COVID-19 Drugs Revenue Market Forecast (2021-2025)

12.6 South America COVID-19 Drugs Revenue Market Forecast (2021-2025)

12.7 Middle East & Africa COVID-19 Drugs Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global COVID-19 Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of COVID-19 Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global COVID-19 Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Market COVID-19 Drugs Revenue (Million USD) Comparison by Regions 2015-2025

Table 5. Global COVID-19 Drugs Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Sanofi Corporate Information, Location and Competitors

Table 7. Sanofi COVID-19 Drugs Major Business

Table 8. Sanofi COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 9. Sanofi SWOT Analysis

Table 10. Sanofi COVID-19 Drugs Product and Solutions

Table 11. Sanofi COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 12. Advanz Pharma Corporate Information, Location and Competitors

Table 13. Advanz Pharma COVID-19 Drugs Major Business

Table 14. Advanz Pharma COVID-19 Drugs Total Revenue (USD Million) (2018-2019)

Table 15. Advanz Pharma SWOT Analysis

Table 16. Advanz Pharma COVID-19 Drugs Product and Solutions

Table 17. Advanz Pharma COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 18. Teva Corporate Information, Location and Competitors

Table 19. Teva COVID-19 Drugs Major Business

Table 20. Teva COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 21. Teva SWOT Analysis

Table 22. Teva COVID-19 Drugs Product and Solutions

Table 23. Teva COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 24. Novartis Corporate Information, Location and Competitors

Table 25. Novartis COVID-19 Drugs Major Business

Table 26. Novartis COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 27. Novartis SWOT Analysis

Table 28. Novartis COVID-19 Drugs Product and Solutions

Table 29. Novartis COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 30. Apotex Corporate Information, Location and Competitors

Table 31. Apotex COVID-19 Drugs Major Business

Table 32. Apotex COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 33. Apotex SWOT Analysis

Table 34. Apotex COVID-19 Drugs Product and Solutions

Table 35. Apotex COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 36. Shanghai Zhongxisanwei Corporate Information, Location and Competitors

Table 37. Shanghai Zhongxisanwei COVID-19 Drugs Major Business

Table 38. Shanghai Zhongxisanwei COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 39. Shanghai Zhongxisanwei SWOT Analysis

Table 40. Shanghai Zhongxisanwei COVID-19 Drugs Product and Solutions

Table 41. Shanghai Zhongxisanwei COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 42. Kyung Poong Corporate Information, Location and Competitors

Table 43. Kyung Poong COVID-19 Drugs Major Business

Table 44. Kyung Poong COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 45. Kyung Poong SWOT Analysis

Table 46. Kyung Poong COVID-19 Drugs Product and Solutions

Table 47. Kyung Poong COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 48. Mylan Corporate Information, Location and Competitors

Table 49. Mylan COVID-19 Drugs Major Business

Table 50. Mylan COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 51. Mylan SWOT Analysis

Table 52. Mylan COVID-19 Drugs Product and Solutions

Table 53. Mylan COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 54. Zydus Cadila Corporate Information, Location and Competitors

Table 55. Zydus Cadila COVID-19 Drugs Major Business

Table 56. Zydus Cadila COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 57. Zydus Cadila SWOT Analysis

Table 58. Zydus Cadila COVID-19 Drugs Product and Solutions

Table 59. Zydus Cadila COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 60. Sun Pharma Corporate Information, Location and Competitors

Table 61. Sun Pharma COVID-19 Drugs Major Business

Table 62. Sun Pharma COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 63. Sun Pharma SWOT Analysis

Table 64. Sun Pharma COVID-19 Drugs Product and Solutions

Table 65. Sun Pharma COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 66. Rising Pharmaceutical Corporate Information, Location and Competitors

Table 67. Rising Pharmaceutical COVID-19 Drugs Major Business

Table 68. Rising Pharmaceutical COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 69. Rising Pharmaceutical SWOT Analysis

Table 70. Rising Pharmaceutical COVID-19 Drugs Product and Solutions

Table 71. Rising Pharmaceutical COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 72. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Information, Location and Competitors

Table 73. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Major Business

Table 74. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 75. Guangzhou Baiyunshan Guanghua Pharmaceutical SWOT Analysis

Table 76. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product and Solutions

Table 77. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 78. Ipca Laboratories Corporate Information, Location and Competitors

Table 79. Ipca Laboratories COVID-19 Drugs Major Business

Table 80. Ipca Laboratories COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 81. Ipca Laboratories SWOT Analysis

Table 82. Ipca Laboratories COVID-19 Drugs Product and Solutions

Table 83. Ipca Laboratories COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 84. KPC Group Corporate Information, Location and Competitors

Table 85. KPC Group COVID-19 Drugs Major Business

Table 86. KPC Group COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 87. KPC Group SWOT Analysis

Table 88. KPC Group COVID-19 Drugs Product and Solutions

Table 89. KPC Group COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 90. Shanghai Pharma Corporate Information, Location and Competitors

Table 91. Shanghai Pharma COVID-19 Drugs Major Business

Table 92. Shanghai Pharma COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 93. Shanghai Pharma SWOT Analysis

Table 94. Shanghai Pharma COVID-19 Drugs Product and Solutions

Table 95. Shanghai Pharma COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 96. Bayer Corporate Information, Location and Competitors

Table 97. Bayer COVID-19 Drugs Major Business

Table 98. Bayer COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 99. Bayer SWOT Analysis

Table 100. Bayer COVID-19 Drugs Product and Solutions

Table 101. Bayer COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 102. Hanlim Pharmaceutical Corporate Information, Location and Competitors

Table 103. Hanlim Pharmaceutical COVID-19 Drugs Major Business

Table 104. Hanlim Pharmaceutical COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 105. Hanlim Pharmaceutical SWOT Analysis

Table 106. Hanlim Pharmaceutical COVID-19 Drugs Product and Solutions

Table 107. Hanlim Pharmaceutical COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 108. CSPC Group COVID-19 Drugs Type and Application

Table 109. CSPC Group COVID-19 Drugs Major Business

Table 110. CSPC Group COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 111. CSPC Group SWOT Analysis

Table 112. CSPC Group COVID-19 Drugs Product and Solutions

Table 113. CSPC Group COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 114. Sichuan Sunny Hope Corporate Information, Location and Competitors

Table 115. Sichuan Sunny Hope COVID-19 Drugs Major Business

Table 116. Sichuan Sunny Hope COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 117. Sichuan Sunny Hope SWOT Analysis

Table 118. Sichuan Sunny Hope COVID-19 Drugs Product and Solutions

Table 119. Sichuan Sunny Hope COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 120. Bristol Laboratories Corporate Information, Location and Competitors

Table 121. Bristol Laboratories COVID-19 Drugs Major Business

Table 122. Bristol Laboratories COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 123. Bristol Laboratories SWOT Analysis

Table 124. Bristol Laboratories COVID-19 Drugs Product and Solutions

Table 125. Bristol Laboratories COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 126. Jinghua Pharmaceutical Group Corporate Information, Location and Competitors

Table 127. Jinghua Pharmaceutical Group COVID-19 Drugs Major Business

Table 128. Jinghua Pharmaceutical Group COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 129. Jinghua Pharmaceutical Group SWOT Analysis

Table 130. Jinghua Pharmaceutical Group COVID-19 Drugs Product and Solutions

Table 131. Jinghua Pharmaceutical Group COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 132. Zhongsheng Pharma Corporate Information, Location and Competitors

Table 133. Zhongsheng Pharma COVID-19 Drugs Major Business

Table 134. Zhongsheng Pharma COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 135. Zhongsheng Pharma SWOT Analysis

Table 136. Zhongsheng Pharma COVID-19 Drugs Product and Solutions

Table 137. Zhongsheng Pharma COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 138. North China Pharmaceutical Group Corporate Information, Location and Competitors

Table 139. North China Pharmaceutical Group COVID-19 Drugs Major Business

Table 140. North China Pharmaceutical Group COVID-19 Drugs Total Revenue (USD Million) (2017-2018)

Table 141. North China Pharmaceutical Group SWOT Analysis

Table 142. North China Pharmaceutical Group COVID-19 Drugs Product and Solutions

Table 143. North China Pharmaceutical Group COVID-19 Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 144. Global COVID-19 Drugs Revenue (Million USD) by Players (2015-2020)

Table 145. Global COVID-19 Drugs Revenue Share by Players (2015-2020)

Table 146. Global COVID-19 Drugs Revenue (Million USD) by Regions (2015-2020)

Table 147. Global COVID-19 Drugs Revenue Market Share by Regions (2015-2020)

Table 148. North America COVID-19 Drugs Revenue by Countries (2015-2020)

Table 149. North America COVID-19 Drugs Revenue Market Share by Countries (2015-2020)

Table 150. Europe COVID-19 Drugs Revenue (Million USD) by Countries (2015-2020)

Table 151. Asia-Pacific COVID-19 Drugs Revenue (Million USD) by Countries (2015-2020)

Table 152. South America COVID-19 Drugs Revenue by Countries (2015-2020)

Table 153. South America COVID-19 Drugs Revenue Market Share by Countries (2015-2020)

Table 154. Middle East and Africa COVID-19 Drugs Revenue (Million USD) by Countries (2015-2020)

Table 155. Middle East and Africa COVID-19 Drugs Revenue Market Share by Countries (2015-2020)

Table 156. Global COVID-19 Drugs Revenue (Million USD) by Type (2015-2020)

Table 157. Global COVID-19 Drugs Revenue Share by Type (2015-2020)

Table 158. Global COVID-19 Drugs Revenue Forecast by Type (2021-2025)

Table 159. Global COVID-19 Drugs Revenue by Application (2015-2020)

Table 160. Global COVID-19 Drugs Revenue Share by Application (2015-2020)

Table 161. Global COVID-19 Drugs Revenue Forecast by Application (2021-2025)

Table 162. Global COVID-19 Drugs Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. COVID-19 Drugs Picture

Figure 2. Global COVID-19 Drugs Revenue Market Share by Type in 2019

Figure 3. Tablet Picture

Figure 4. Injection Picture

Figure 5. COVID-19 Drugs Revenue Market Share by Application in 2019

Figure 6. Mild Symptom Patient Picture

Figure 7. Critically Ill Patient Picture

Figure 8. Global COVID-19 Drugs Revenue (USD Million) and Growth Rate (2015-2025)

Figure 9. North America COVID-19 Drugs Revenue (Million USD) and Growth Rate (2015-2025)

Figure 10. Europe COVID-19 Drugs Revenue (Million USD) and Growth Rate (2015-2025)

Figure 11. Asia-Pacific COVID-19 Drugs Revenue (Million USD) and Growth Rate (2015-2025)

Figure 12. South America COVID-19 Drugs Revenue (Million USD) and Growth Rate (2015-2025)

Figure 13. Middle East and Africa COVID-19 Drugs Revenue (Million USD) and Growth Rate (2015-2025)

Figure 14. Global COVID-19 Drugs Revenue (Million USD) and Growth Rate (2015-2025)

Figure 15. Global COVID-19 Drugs Revenue Share by Players in 2019

Figure 16. Global Top 5 Players COVID-19 Drugs Revenue Market Share in 2019

Figure 17. Global Top 10 Players COVID-19 Drugs Revenue Market Share in 2019

Figure 18. Key Players Market Share Trend

Figure 19. Global COVID-19 Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)

Figure 20. Global COVID-19 Drugs Revenue Market Share by Regions (2015-2020)

Figure 21. Global COVID-19 Drugs Revenue Market Share by Regions in 2018

Figure 22. North America COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 23. Europe COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 24. Asia-Pacific COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 25. South America COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 26. Middle East and Africa COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 27. North America COVID-19 Drugs Revenue Market Share by Countries (2015-2020)

Figure 28. North America COVID-19 Drugs Revenue Market Share by Countries in 2019

Figure 29. USA COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 30. Canada COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 31. Mexico COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 32. Europe COVID-19 Drugs Revenue Market Share by Countries (2015-2020)

Figure 33. Europe COVID-19 Drugs Revenue Market Share by Countries in 2019

Figure 34. Germany COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 35. UK COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 36. France COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 37. Russia COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 38. Italy COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 39. Asia-Pacific COVID-19 Drugs Revenue Market Share by Countries (2015-2020)

Figure 40. Asia-Pacific COVID-19 Drugs Revenue Market Share by Countries in 2019

Figure 41. China COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 42. Japan COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 43. Korea COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 44. India COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 45. Southeast Asia COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 46. South America COVID-19 Drugs Revenue Market Share by Countries (2015-2020)

Figure 47. South America COVID-19 Drugs Revenue Market Share by Countries in 2019

Figure 48. Brazil COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 49. Argentina COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 50. Middle East and Africa COVID-19 Drugs Revenue Market Share by Countries (2015-2020)

Figure 51. Middle East and Africa COVID-19 Drugs Revenue Market Share by Countries in 2019

Figure 52. Saudi Arabia COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 53. UAE COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 54. Egypt COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 55. South Africa COVID-19 Drugs Revenue and Growth Rate (2015-2020)

Figure 56. Global COVID-19 Drugs Revenue Share by Type (2015-2020)

Figure 57. Global COVID-19 Drugs Revenue Share by Type in 2019

Figure 58. Global COVID-19 Drugs Market Share Forecast by Type (2021-2025)

Figure 59. Global Tablet Revenue Growth Rate (2015-2020)

Figure 60. Global Injection Revenue Growth Rate (2015-2020)

Figure 61. Global COVID-19 Drugs Revenue Share by Application (2015-2020)

Figure 62. Global COVID-19 Drugs Revenue Share by Application in 2019

Figure 63. Global COVID-19 Drugs Market Share Forecast by Application (2021-2025)

Figure 64. Global Mild Symptom Patient Revenue Growth Rate (2015-2020)

Figure 65. Global Critically Ill Patient Revenue Growth Rate (2015-2020)

Figure 66. Global COVID-19 Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)

Figure 67. Global COVID-19 Drugs Revenue (Million USD) Forecast by Regions (2021-2025)

Figure 68. Global COVID-19 Drugs Revenue Market Share Forecast by Regions (2021-2025)

Figure 69. North America COVID-19 Drugs Revenue Market Forecast (2021-2025)

Figure 70. Europe COVID-19 Drugs Revenue Market Forecast (2021-2025)

Figure 71. Asia-Pacific COVID-19 Drugs Revenue Market Forecast (2021-2025)

Figure 72. South America COVID-19 Drugs Revenue Market Forecast (2021-2025)

Figure 73. Middle East and Africa COVID-19 Drugs Revenue Market Forecast (2021-2025)

Figure 74. Sales Channel: Direct Channel vs Indirect Channel